Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
This study is testing a new, non-invasive device called Sphere V3.0 to see if it can help improve movement problems in people with Parkinson's disease. The device uses gentle electrical signals applied to the scalp. You might be able to join if you are 18-80 years old, have a confirmed Parkinson's diagnosis (Hoehn & Yahr stages 1-4), and have stable medications. The main goal is to see if the device improves your motor symptoms, measured by a standard rating scale (MDS-UPDRS Part III Motor Scores) after 3 weeks of treatment. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study with a planned enrollment of 30 participants. It is conducted virtually.
- What's involved
- You would use the device at home for 13 minutes each weekday (Monday through Friday) for 3 weeks. The entire study lasts 6 weeks, with virtual assessments and video recordings of your movements.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be monitored for 3 weeks after the treatment period ends.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
At a glance
Conditions
NCT07182058
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
U LLC Headquarters
Cleveland, Ohiostudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in MDS-UPDRS Part III Motor ScoresBaseline to Week 3 (end of treatment)
Change from baseline to end of treatment in Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III motor examination scores. The MDS-UPDRS Part III assesses motor signs of Parkinson's disease including tremor, rigidity, bradykinesia, and postural instability. Scores range from 0-132 with higher scores indicating worse motor function. All assessments conducted by qualified medical personnel including physicians, certified research coordinators, or trained clinical research assistants under physician supervision.